课题基金 / 基金详情

Surface-enhanced Raman Spectroscopy Immunoassay for Detection of Category A Patho

Surface-enhanced Raman Spectroscopy Immunoassay for Detection of Category A Patho
用于检测 A 类病理的表面增强拉曼光谱免疫分析
批准号:
9278001
负责人:
Marc D Porter
金额:
$61.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-06-01 至 2019-05-31
关键词:
Anthrax diseaseAntigensApplications GrantsArtsBacillus anthracisBindingBiologicalBiological AssayBiological WarfareBotulinum ToxinsBotulismCategoriesCertificationCharacteristicsChemicalsChemistryClinicalCommunicationContainmentCountryData AnalysesDetectionDevelopmentDiagnosticDiagnostic SensitivityDiagnostic SpecificityDiagnostic testsDiseaseEngineeringEquipmentEventFDA approvedFiber OpticsGoalsGoldHuman ResourcesImmunoassayImmunological DiagnosisIn VitroLabelLaboratoriesLaboratory ProceduresLaboratory ResearchLasersLegal patentLiquid substanceMeasurementMedical DeviceMethodsMonoclonal AntibodiesNational Institute of Allergy and Infectious DiseasePathologyPathway interactionsPerformancePhasePlaguePreparationProbabilityProcessPublic HealthRaman Spectrum AnalysisReadingRecombinantsRecording of previous eventsReporterResource DevelopmentSafetySamplingScientistSecuritySeriesSerumSerum MarkersSignal TransductionSourceSpecificitySpeedSurfaceSystemTechnologyTestingTrainingUniversitiesUtahValidationVirusWireless TechnologyWorkYersinia pestisactive methodbasebiodefensebiosafety level 3 facilitybotulinumcombatcostcost effectivenessdesigndiagnostic biomarkerdiagnostic panelexperienceimprovedinnovationinstrumentinstrumentationlight weightmedical schoolsmicroorganism toxinmonolayermultiplex detectionnanoparticleparticlepathogenpathogen exposureportabilityprototypepublic health emergencypublic health relevancerapid detectionrapid techniquesurfactanttechnique developmenttherapeutic developmenttoolvaccine developmentweapons of mass destruction

项目摘要

项目成果

Marc D Porter的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):最近的事件使得对NIAID A类优先病原体(A类病原体)的快速、低水平检测的可靠技术的开发需求处于更加关键的水平。该项目将开发可部署的、基于纳米粒子的表面增强拉曼散射(SERS)诊断测试来满足这一需求。在此过程中,本项目将重点研究三种血清标记物
英文摘要
DESCRIPTION (provided by applicant): Recent events have placed the need for the development of reliable techniques for the rapid, low-level detection of NIAID Category A Priority Pathogens (Category A Pathogens) at an even more critical level. This project will develop deployable, nanoparticle-based, surface enhanced Raman scattering (SERS) diagnostic tests to fill this need. In so doing, this project will focus on serum markers for three well characterized Category A Pathogens (i.e., Bacillus anthracis, Clostridium botulinum toxin, and Yersinia pestis) in devising and performance-validating a multiplexed diagnostic panel based on the ultrasensitive detection of extrinsic Raman labels (ERLs) selectively bound to captured active pathogen antigens. ERLs will use unique Raman reporter molecules (RRMs) and monoclonal antibodies (mAbs) to selectively bind to captured antigens and to generate a markedly enhanced signal for ultra-low-level detection. Concurrently, we will also design and manufacture prototypes of a lightweight integrated, closed, sample-to-answer platform capable of reading the characteristic SERS spectrum from the ERLs when excited by a new diode laser. The platform will be field-deployable, have a desktop printer-size footprint, and have a readout of ~2 min for a 96-well microplate. As assays for the deactivated pathogens are validated in the laboratory the procedures will be transferred into a BSL-3 facility where methods for the active Category A Pathogen markers will be validated. When the prototypic Raman instruments and panel kits are available, they will be beta-tested and performance validated in the research laboratory (with deactivated markers) and in the BSL-3 facility (with active markers) at the U.S. Army's Dugway Proving Ground (DPG). This project represents a partnership between scientists and engineers at the University of Utah, B&W Tek, Inc. (a global leader in Raman spectroscopy and related automated instrumentation), and DPG.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Field-deployable platform for prognostic hepatic cancer screening in low-resource settings
  • 批准号:
    9221887
  • 项目类别:
  • 资助金额:
    $39.99万
  • 财政年份:
    2017
  • 负责人:
    Marc D Porter
  • 依托单位:
Surface-enhanced Raman Spectroscopy Immunoassay for Detection of Category A Patho
  • 批准号:
    8695035
  • 项目类别:
  • 资助金额:
    $91.82万
  • 财政年份:
    2014
  • 负责人:
    Marc D Porter
  • 依托单位:
Surface-enhanced Raman Spectroscopy Immunoassay for Detection of Category A Patho
  • 批准号:
    8850810
  • 项目类别:
  • 资助金额:
    $61.78万
  • 财政年份:
    2014
  • 负责人:
    Marc D Porter
  • 依托单位:
Surface-enhanced Raman Spectroscopy Immunoassay for Detection of Category A Patho
  • 批准号:
    9067315
  • 项目类别:
  • 资助金额:
    $64.89万
  • 财政年份:
    2014
  • 负责人:
    Marc D Porter
  • 依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究